Major IVD vendors, especially those common in reverse transcription PCR (RT-PCR), went right to work in the recent coronavirus outbreak. This as the FDA announced plans to make emergency test deployment easier. The recent novel coronavirus, responsible for thousands of infections and over 170 deaths in the Hubei province in China at the time of […]
[by Christina Chew] It is increasingly common to test in panels to gain clarity on disease while treatment will be most effective. Numerous multiplex products are on the market, and their effectiveness has been shown in studies, but there are challenges with reimbursement. In this article, we will look at the current status of syndromic […]
Make sure to visit our In Vitro Diagnostics page, Kalorama’s all-in-one resource covering the IVD market. Infectious Disease Molecular IVD Market: Fastest Growth of Any Molecular Test Segment Infectious Disease is the best-selling and fastest-growing part of molecular testing, as Kalorama notes in its report Infectious Disease Diagnostics. Molecular diagnostics’ performance and applicability is unparalleled among IVD […]
